# MapLight shares sink on mixed ph. 2 schizophrenia readout

> **Open Intelligence Dossier** · First detected: 2026-07-27 23:07 UTC · Category: Business

## Executive Summary
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"MapLight shares sink on mixed ph. 2 schizophrenia readout" is generating significant coverage in the Business category, with 8 articles from 7 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance, BioWorld News, BioPharma Dive and simplywall.st. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | Maplight Therapeutics’ Schizophrenia Drug Hits Phase II Primary Endpoint | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxPcUpDNWNBcVZpY2o4VFZNLWJrWEJKajBZdWdmTDZzZjdKOWM5ZVZZWXg3UVc5VUFCaWdrSHJ2Vllvbmh1OTdRVFV3RzBqQkgtcE1yX3RkYWNfQ2Z6MG51azlza0hSTC1LeXJLV2xLTWRUaUxLWXY0Mk1xcXVxNGZVcmE1VDdRbFNVczNheVFSTmFjQzdlcTFrQTBmSEwwUGJGQ3o4ZTIwT2ZoUQ?oc=5) |
| Yahoo Finance | MPLT Stock Plunges 73% — Wipes Out Over $1B In Market Cap After Trial Miss On Once-Daily Dose | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxQcEh2TDJnaHpSUG5uanUtRWFFa3F4MnVVc0xhclJqY1pJcXdFNzFrcmRlMGxvVVJlNW9UaU9MRFpzNV9xWVVvMFpYMWZtVkFCQlVvdU5RUE93S2hMQjNGTHRBVHpKZDA0N3dKWlA2aFZnV1k1dHlXWFQ5b3F3ZFhQNTI5QS1GTTNNTkt1cHRBX3JhUQ?oc=5) |
| BioWorld News | Maplight aims to differentiate muscarinic agonist from competitors | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxOaUh2OHNidG8tUjA0UDA2a2tlZGluRjhEOWRsY1NMaEU4UnJtOEFZUVViSnl6djRZc0cxMHlPS21pcGZiZFZTZkVZMlhNenA3V05CcnVRWnVENzhDQ3cxV2lQeW9sMTRiOGd4dXRVb2R1QjRVZmhZelZQYzdJajA1cGljX05KQ1hGdm5HNmNoeEJzSDdQMmpDa2ZtbjR1Z01FRm8yWWlJZzIxNW8?oc=5) |
| BioPharma Dive | MapLight dives despite positive data for schizophrenia drug | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxPejBoV244TnByVEc2SUpaRFF3MzlmZkU4elNYMUluTDh0OEJLc1RUWUhUTGg1SlBHVUdSYVJ1ZVFpbGxfUkljNkhkM3RFM1dRZFZMMlA0UWJVRTY2N0hHT29yVmpyNEhRcHdJWTRJVDUzaFpyaXpVcG15RFlBTHVJYUJMekRaaVBObGFoRXI0Q3ZkOTRuVk84YnBhaVdwZ28?oc=5) |
| simplywall.st | MapLight Therapeutics (MPLT) Rally Puts Its CNS Story And Valuation In Focus | [Source Link](https://news.google.com/rss/articles/CBMi6wFBVV95cUxNQVVNc0ZRaGVSNGVobEdwMUllTDN4NVotZ1o0RFFhUEtJaFNVMFNMalc1LTVZNk9IZmMwb2dNZUdOU3hZVFZiNU9IUHAzamdUSkpEV1pCNlNMdTZZc2k3TW9ZbnZZMm5ITzZrUTJWWTZ1TmhXN3p6RlBocUJnSzFOS01hWUR4Mzh2RC1keVpjMVZ5VTFLcVlLSWZobkhjVUFBOFlCTTdHOVRnU3REb1pndWlkd0NUR1Q5MndiSmxtc1N5dWlYa21iZ2MxNHVTWGRjbE9Wa0F5RGVNT1FZTEE3WnBnLWotQ1lHUzlR0gHwAUFVX3lxTE1sMUFWZ3JUMXpfRFJaYXYwd3Z3Yk9tMVVINU13OF9uME1YbXhHdzE3b1ZYQllfYWVXMWdFOVloUmoyWkJDOHMzMkd6cjFlUUdhZlJBZEN6UXVKN2hKZ2dhbGlXX1dNY0I) |
| Finimize | Biotech And AI Stocks Got Hit On Mixed News | [Source Link](https://news.google.com/rss/articles/CBMifEFVX3lxTFBCTXNiZzBZRzJ3TWRIUkxVelZFalZXUkYwMlN1NzRfYVJ3WVhXVDRVYTlyOTZkeENjdnVLN3VqSjEzZ2dfZGFkOHp3VGwxNHlUUHdhSEtZaS1kSk85bnp0SGMwTWlDcHZNTWpnMXczYkRNQmJfYXVqRDlxQWI?oc=5) |
| Psychiatric Times | Phase 2 Topline Results From ZEPHYR Trial: ML-007C-MA for the Treatment of Schizophrenia | [Source Link](https://news.google.com/rss/articles/CBMiwwFBVV95cUxNaURoamR5VU5nbW5CM0VrVFYyUW85MzhRVjBzRHRTeldRbGRTX292MS1kZFJlWmlRaWQwZ3d3Vm85MlFBM2dnZ3BLLWZabTBkR2hVNnh1RVhPY1R5b2tuTlJzUlJBeThJVlRBMWdDclNGSFNDcG55S1VVVUFwUi1Oai0xUmZFeUk4M3VpOGgzTzRSTzg3STZDVU56c2FVZWRMUTZzclRPb3lQQzRtaDNUUXdkNEUydEdFd25RVWVLY0VDeUk?oc=5) |
| Fierce Biotech | MapLight shares sink on mixed ph. 2 schizophrenia readout | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxNaGRCajhpNlhOdEFyNlFsdWN6T1Y0YzZaQUZseXE2c0dyVzdmR05sbVRSTHRKYjQ1WHdNYWtHaUpIMFJrX24yaVp2VTVhV3N5N1dwLVBqQUlYVFpQOEQ4UUFzSkt4dzhaWkx6bGN2a2xONmdaMmMxanQxRGpESWkwQ1lBZ0haWUxJT0lEMXFNWU1LM0ZXeVE?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-27/maplight-shares-sink-on-mixed-ph-2-schizophrenia-readout*